Lifeward (LFWD) Capital Expenditures Growth (3y) (2018 - 2025)

Lifeward (LFWD) Capital Expenditures Growth (3y) (2018 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (3y) (Qtr)
1 Abbott Laboratories 181.51 Bn 174.22 Bn 6.27 Bn 1.64%
2 Stryker 128.20 Bn 125.32 Bn 3.81 Bn 8.49%
3 Medtronic 107.69 Bn 98.47 Bn 6.41 Bn 8.89%
4 Boston Scientific 68.05 Bn 66.59 Bn 3.61 Bn 16.83%
5 Edwards Lifesciences 47.52 Bn 43.85 Bn 1.29 Bn 1.81%
6 GE HealthCare Technologies 28.46 Bn 26.17 Bn 1.98 Bn 7.57%
7 Dexcom 28.25 Bn 27.13 Bn 750.30 Mn 0.84%
8 Smith & Nephew 26.73 Bn 26.15 Bn - -
9 Koninklijke Philips 25.31 Bn 22.19 Bn 2.07 Bn 2.15%
10 Lifeward 11.36 Mn -64,668.24 1.34 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 18.56%
Sep 30, 2023 -67.45%
Dec 31, 2021 23.86%
Sep 30, 2021 41.50%
Sep 30, 2020 177.34%
Jun 30, 2020 -20.63%
Mar 31, 2020 -3.45%
Dec 31, 2019 -31.73%
Dec 31, 2018 -59.63%
Sep 30, 2018 -58.00%